Piper Sandler Initiates Coverage On TransMedics Gr with Overweight Rating, Announces Price Target of $95
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Matt O'Brien initiates coverage on TransMedics Gr (NASDAQ:TMDX) with an Overweight rating and a price target of $95.
March 28, 2024 | 11:06 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler initiated coverage on TransMedics Gr with an Overweight rating and set a price target of $95.
The initiation of coverage by Piper Sandler with an Overweight rating and a high price target of $95 suggests a positive outlook on TransMedics Gr's stock. This could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100